Match!

Pirfenidone reduces subchondral bone loss and fibrosis after murine knee cartilage injury

Published on Jul 21, 2017in Journal of Orthopaedic Research3.043
· DOI :10.1002/jor.23635
Deva D. Chan12
Estimated H-index: 12
,
Jun Li18
Estimated H-index: 18
+ 3 AuthorsAnna Plaas41
Estimated H-index: 41
Abstract
Pirfenidone is an anti-inflammatory and anti-fibrotic drug that has shown efficacy in lung and kidney fibrosis. Because inflammation and fibrosis have been linked to the progression of osteoarthritis, we investigated the effects of oral Pirfenidone in a mouse model of cartilage injury, which results in chronic inflammation and joint-wide fibrosis in mice that lack hyaluronan synthase 1 (Has1−/−) in comparison to wild-type. Femoral cartilage was surgically injured in wild-type and Has1−/− mice, and Pirfenidone was administered in food starting after 3 days. At 4 weeks, Pirfenidone reduced the appearance, on micro-computed tomography, of pitting in subchondral bone at, and cortical bone surrounding, the site of cartilage injury. This corresponded with a reduction in fibrotic tissue deposits as observed with gross joint surface photography. Pirfenidone resulted in significant recovery of trabecular bone parameters affected by joint injury in Has1–/– mice, although the effect in wild-type was less pronounced. Pirfenidone also increased Safranin-O staining of growth plate cartilage after cartilage injury and sham operation in both genotypes. Taken together with the expression of selected extracellular matrix, inflammation, and fibrosis genes, these results indicate that Pirfenidone may confer chondrogenic and bone-protective effects, although the well-known anti-fibrotic effects of Pirfenidone may occur earlier in the wound-healing response than the time point examined in this study. Further investigations to identify the specific cell populations in the joint and signaling pathways that are responsive to Pirfenidone are warranted, as Pirfenidone and other anti-fibrotic drugs may encourage tissue repair and prevent progression of post-traumatic osteoarthritis. This article is protected by copyright. All rights reserved
  • References (73)
  • Citations (2)
📖 Papers frequently viewed together
8 Authors (Wenbo Mu, ..., Li Cao)
1 Citations
12 Authors (Yicheng Li, ..., Li Cao)
1 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References73
Newest
#1Chenyu Huang (THU: Tsinghua University)H-Index: 9
#2Longwei Liu (THU: Tsinghua University)H-Index: 5
Last. Rei Ogawa (Nippon Medical School)H-Index: 34
view all 7 authors...
Summary Hypertrophic scars/keloids are pathogenic scars that are characterized by collagen and fibroblast accumulation. The endothelia in the lesions are mechanosensitive and participate actively in the pathogenesis of these scars. The present review summarizes how endothelium responds to mechanical stimuli such as shear, stretch and hydrostatic pressure. It also shows that in heart, liver, kidney and lung fibrosis, endothelial dysfunctions (EDs) associate with changes in vascular tone, endothel...
4 CitationsSource
#1C Y Yang (Arthritis Research UK)H-Index: 1
#2Anastasios Chanalaris (Arthritis Research UK)H-Index: 15
Last. Linda Troeberg (Arthritis Research UK)H-Index: 25
view all 3 authors...
Summary Introduction Matrix metalloproteinases (MMPs) and ‘aggrecanase' a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs) are well established to play key roles in osteoarthritis (OA) through degradation of extracellular matrix (ECM) type II collagen and aggrecan, and are thus potential targets for development of OA therapies. Objective This paper aims to provide a comprehensive review of the expression and potential roles of other, lesser-known ADAMTSs and related adamaly...
34 CitationsSource
#1Ali MobasheriH-Index: 56
#2Margaret P. RaymanH-Index: 37
Last. Ursula FearonH-Index: 37
view all 6 authors...
Metabolism is important for cartilage and synovial joint function. Under adverse microenvironmental conditions, mammalian cells undergo a switch in cell metabolism from a resting regulatory state to a highly metabolically activate state to maintain energy homeostasis. This phenomenon also leads to an increase in metabolic intermediates for the biosynthesis of inflammatory and degradative proteins, which in turn activate key transcription factors and inflammatory signalling pathways involved in c...
76 CitationsSource
#1Miroslava DidiasovaH-Index: 10
#2Rajeev SinghH-Index: 4
Last. Malgorzata Wygrecka (University of Giessen)H-Index: 27
view all 11 authors...
Pirfenidone is an antifibrotic drug, recently approved for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Although pirfenidone exhibits anti-inflammatory, antioxidant, and anti...
27 CitationsSource
Chondrocytes of the growth plate undergo apoptosis during the process of endochondral ossification, as well as during the progression of osteoarthritis. Although the regulation of this process is not completely understood, alterations in the precisely orchestrated programmed cell death during development can have catastrophic results, as exemplified by several chondrodystrophies which are frequently accompanied by early onset osteoarthritis. Understanding the mechanisms that underlie chondrocyte...
18 CitationsSource
Certain types of joint injuries, common in athletes, are known to have a high association with the development of osteoarthritis (OA). Post-traumatic osteoarthritis (PTOA) is especially debilitating due to its earlier onset than traditional OA, and its predisposition to affect a younger and more active population. Five common athletic injuries have been demonstrated to be risk factors for the development of OA. These include ACL rupture, meniscus tear, glenohumeral instability, patellar dislocat...
28 CitationsSource
#1C. Blaker (USYD: University of Sydney)H-Index: 3
#2Elizabeth Clarke (USYD: University of Sydney)H-Index: 17
Last. Christopher B. Little (USYD: University of Sydney)H-Index: 45
view all 3 authors...
Post-traumatic osteoarthritis (PTOA) is defined by its development after joint injury. Factors contributing to the risk of PTOA occurring, the rate of progression, and degree of associated disability in any individual, remain incompletely understood. What constitutes an "OA-inducing injury" is not defined. In line with advances in the traumatic brain injury field, we propose the scope of PTOA-inducing injuries be expanded to include not only those causing immediate structural damage and instabil...
19 CitationsSource
#1Zhensen Zhu (STU: Shantou University)H-Index: 5
#2DingJie (U of A: University of Alberta)H-Index: 18
Last. Edward E. Tredget (U of A: University of Alberta)H-Index: 51
view all 3 authors...
Hypertrophic scars (HTS) are caused by dermal injuries such as trauma and burns to the deep dermis, which are red, raised, itchy and painful. They can cause cosmetic disfigurement or contractures if craniofacial areas or mobile region of the skin are affected. Abnormal wound healing with more extracellular matrix deposition than degradation will result in HTS formation. This review will introduce the physiology of wound healing, dermal HTS formation, treatment and difference with keloids in the ...
28 CitationsSource
#1Ronald K. JuneH-Index: 11
#2Ru Liu-BryanH-Index: 22
Last. Timothy M. GriffinH-Index: 20
view all 4 authors...
Abstract Obesity and associated metabolic diseases collectively referred to as the metabolic syndrome increase the risk of skeletal and synovial joint diseases, including osteoarthritis (OA). The relationship between obesity and musculoskeletal diseases is complex, involving biomechanical, dietary, genetic, inflammatory, and metabolic factors. Recent findings illustrate how changes in cellular metabolism and metabolic signaling pathways alter skeletal development, remodeling, and homeostasis, es...
21 CitationsSource
#1Gareth HughesH-Index: 2
#2Hannah ToellnerH-Index: 2
Last. Nazia ChaudhuriH-Index: 11
view all 5 authors...
Idiopathic Pulmonary Fibrosis (IPF) now has two licensed treatments available. Pirfenidone was the first drug to be licensed and approved for use, followed by nintedanib. We set out our real world experience with these agents in terms of their adverse events profile outside the restrictions of a clinical trial. We have demonstrated in the real world setting, that side effects are common and predominantly gastrointestinal with both therapies. Our study shows that the side effects can be effective...
58 CitationsSource
Cited By2
Newest
#1Edith CharlierH-Index: 8
#2Céline DeroyerH-Index: 5
Last. Dominique de SenyH-Index: 16
view all 8 authors...
Abstract Osteoarthritis (OA) is a degenerative joint disease characterized by progressive cartilage degradation but also synovial membrane inflammation, osteophyte formation and subchondral bone sclerosis. Medical care is mainly based on alleviating pain symptoms, but to date, no effective drug can stop the disease progression. Cartilage is a tissue composed of only one cell type, chondrocytes, wrapped in a collagen rich extracellular matrix they synthesize. Chondrocytes can adopt different phen...
7 CitationsSource
#1Katie J. SikesH-Index: 2
#2Kristen RennerH-Index: 2
Last. Vincent M. WangH-Index: 26
view all 10 authors...
2 CitationsSource